Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when OM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOutset Medical stockholders approve executive pay, re-elect directors at annual meeting
Filed June 5, 2026 · Period ending June 4, 2026 · ~1 min read
Key Changes
-
medium
Shareholders approved 2025 executive compensation with 70% support (7.5M for vs 3.2M against), indicating moderate backing for management's pay practices in a non-binding advisory vote.
Item 5.07: Say-on-Pay verify on EDGAR → -
low
Brent D. Lang and Karen Prange re-elected as Class III directors with terms through 2029. Lang received 75% support while Prange received 96% approval from voting shareholders.
Item 5.07: Director Elections verify on EDGAR → -
low
KPMG LLP ratified as independent auditor for 2026 with near-unanimous approval (99.8% of votes cast), maintaining continuity in external audit relationship.
Item 5.07: Auditor Ratification verify on EDGAR →
Summary
Outset Medical completed its 2026 Annual Meeting on June 4 with routine governance outcomes. The most notable result was the say-on-pay vote, where 70% of shareholders approved executive compensation for 2025. While this represents majority support, the 30% opposition is worth monitoring as it suggests some investor concern about pay practices.
Both director nominees were re-elected, though Brent Lang's lower approval rate (75% vs Prange's 96%) may indicate shareholder questions about board composition or performance. For retail investors, this filing signals business-as-usual governance with no major surprises or controversies. The say-on-pay result, while passing, is the only item warranting attention. Watch for the company's next proxy statement to see if management addresses shareholder feedback on compensation or makes adjustments to pay structures in response to the dissenting votes.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Outset Medical held its 2026 Annual Meeting, electing two Class III directors, approving executive compensation, and ratifying KPMG as auditor.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
Each of Brent D. Lang and Karen Prange was elected to serve as a class III director to hold office until the Company’s 2029 annual meeting of stockholders and until the election and qualification of his or her successor.
Brent D. Lang and Karen Prange were elected as Class III directors at the June 4, 2026 Annual Meeting, with terms extending until the 2029 annual meeting. Lang received 8,109,357 votes for with 2,642,698 withheld, while Prange received 10,317,822 votes for with 434,233 withheld.
Added in current filing · verify on EDGAR →
The stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 by the following vote:
For | Against | Abstain | Broker Non-Votes | 13,554,287 | 20,047 | 316,530 | —
Stockholders ratified KPMG LLP as the independent auditor for fiscal year 2026 with overwhelming support of 13,554,287 votes for versus only 20,047 against. This routine approval confirms continuity in the company's external audit relationship.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify